Then, the multivariate logistic regression analysis demonstrated that SCARA5 expression (OR = 0.537, 95% CI = 0.340‐0.847, P = .008), lymph node metastasis (OR = 1.858, 95% CI = 1.166‐2.959, P = .009), disease stage (OR = 4.129, 95% CI = 2.337‐7.292, P < .001) intensified the risk of tumour growth (Table 4). This evidence concerns the gene SCARA5 and metastatic malignant neoplasm in the lymph nodes.